Story SARS-CoV-2 LC-MS Kit (RUO) Detect & quantify SARS-CoV-2 NCAP peptides with LC-MS to advance research of the SARS-CoV-2 virus. Waters SARS-CoV-2 LC-MS Kit (RUO) can directly detect and quantify SARS-CoV-2 signature NCAP peptides, without the need to amplify the target analytes. The global COVID-19 pandemic created an unprecedented requirement to quickly deploy emergency tests for SARS-CoV-2 infection. Now, scientists can harness the flexibility and reproducibility of LC-MS to advance critical SARS-CoV-2 research. Waters SARS-CoV-2 LC-MS Kit (RUO) can directly detect and quantify SARS-CoV-2 signature NCAP peptides, without the need to amplify the target analytes. With an automatable workflow, reagents manufactured under strict quality controls, and a reproducible method: Achieve reproducible results between and within labs Ensure high accuracy and analytical sensitivity to enable critical research Empower research and development of pioneering SARS-CoV-2 testing, using an alternative and complementary technology to common infectious pathogen research Because the method runs on an LC-MS platform it has the potential be multiplexed with other peptides and biomarkers for broader research Please note: This kit is for research use only and has not been approved for use in clinical diagnostic procedures. This RUO kit has not been tested with clinical samples. Click here to learn more about the SARS-CoV-2 LC-MS Kit (RUO). Automation Save valuable time, allowing you to focus on your research, with reliable and reproducible sample preparation using the Andrew+ Pipetting Robot. The SARS-CoV-2 LC-MS Kit (RUO) comes in an automation-friendly format with liquid handling protocols for the Andrew+ Pipetting Robot available on OneLab. Consumables compatible with automation Flexible automation platform easily adaptable to multiple workflows SARS-CoV-2 LC-MS Kit (RUO) automation protocol available for Andrew + Pipetting Robot Click here to learn more about our automation solution.